Green Valley Drugs Recalls Dexpanthenol Injection Due to Sterility Concerns
Green Valley Drugs is recalling 273 vials of Dexpanthenol Injection nationwide due to a lack of assurance of sterility and quality control concerns.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score (4) under the rubric for drug recalls involving significant health risks like sterility failures.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 273 vials of Dexpanthenol Injection, prescription only, in all strengths and presentations. The affected products include Dexpanthenol 250 mg/30 mL, Dexpanthenol 250 mg/mL 10 mL, 30 mL, and 50 mL, and Dexpanthenol 250 mg/mL 10 mL P.F. The recall is being conducted nationwide.
The recall is due to a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. The FDA cited concerns associated with the quality control processes as the reason for the recall.
Affected lot numbers include 20130212-A (Exp 5/12/2013), 20130122-E (Exp 4/22/2013), and 20130212-D (Exp 5/12/2013). Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the affected products.
The recalled product
- Product
- Dexpanthenol Injection, all strengths and all presentations including Dexpanthenol 250 mg/30 mL; Dexpanthenol 250 mg/mL 10 mL, 30 mL, 50 mL; and Dexpanthenol 250 mg/mL 10 mL P.F.; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 273
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 20130212-A
- Exp 5/12/2013
- 20130122-E
- Exp 4/22/2013
- 20130212-D
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereDowning Labs Recalls Dexpanthenol Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SeverePromise Pharmacy Recalls Dexpanthenol Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereWellness Pharmacy Recalls Dexpanthenol Vials Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereDexpanthenol Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2018-11-07
- SevereAxia Pharmaceutical Recalls Dexpanthenol Injection Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- SevereDexpanthenol Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23